HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noriaki Nakaya Selected Research

Myocardial Infarction

1/2011Relationships between plasma fatty acid composition and coronary artery disease.
3/2007Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noriaki Nakaya Research Topics

Disease

26Hypercholesterolemia
06/2012 - 06/2002
12Coronary Disease (Coronary Heart Disease)
09/2011 - 05/2002
9Cardiovascular Diseases (Cardiovascular Disease)
06/2012 - 09/2006
9Coronary Artery Disease (Coronary Atherosclerosis)
01/2012 - 03/2007
8Hypertension (High Blood Pressure)
03/2012 - 11/2005
5Stroke (Strokes)
09/2009 - 11/2005
4Obesity
03/2010 - 06/2006
3Hyperlipidemias (Hyperlipidemia)
01/2017 - 01/2002
3Cerebral Infarction
02/2009 - 09/2005
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2012 - 01/2005
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2012 - 09/2005
2Atherosclerosis
01/2012 - 05/2002
2Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2011 - 03/2007
2Unstable Angina
01/2011 - 03/2007
2Myocardial Infarction
01/2011 - 03/2007
2Diabetes Mellitus
10/2009 - 10/2008
2Type 2 Diabetes Mellitus (MODY)
04/2007 - 02/2007
2Hypertriglyceridemia
09/2003 - 05/2002
1Heart Diseases (Heart Disease)
03/2012
1Peripheral Arterial Disease
07/2010
1Dyslipidemias (Dyslipidemia)
02/2009
1Abdominal Obesity
08/2006
1Cerebral Hemorrhage
09/2005

Drug/Important Bio-Agent (IBA)

21LipidsIBA
03/2012 - 12/2002
12Pravastatin (Pravachol)FDA LinkGeneric
06/2012 - 06/2002
10CholesterolIBA
06/2012 - 12/2002
10HDL CholesterolIBA
03/2012 - 09/2003
9LDL CholesterolIBA
01/2017 - 09/2005
9Simvastatin (Zocor)FDA LinkGeneric
03/2010 - 12/2002
8Triglycerides (Triacylglycerol)IBA
01/2017 - 05/2002
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2012 - 01/2008
6oxidized low density lipoproteinIBA
03/2012 - 04/2007
6Eicosapentaenoic AcidIBA
01/2012 - 07/2008
4Glucose (Dextrose)FDA LinkGeneric
10/2009 - 08/2006
2Fenofibrate (CiL)FDA LinkGeneric
01/2017 - 09/2003
2FluvastatinFDA Link
03/2012 - 01/2011
2pitavastatin (itavastatin)FDA Link
06/2002 - 01/2002
1Ezetimibe (Zetia)FDA Link
01/2017
1A 19IBA
01/2012
1Fatty Acids (Saturated Fatty Acids)IBA
01/2011
1Immunoglobulin M (IgM)IBA
10/2009
1Lipoprotein(a)IBA
09/2009
1Blood Glucose (Blood Sugar)IBA
04/2007
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
03/2007
1LeptinIBA
06/2006
1Transaminases (Aminotransferases)IBA
09/2003
1ApolipoproteinsIBA
09/2003
1Apolipoprotein A-I (Apolipoprotein A1)IBA
09/2003
1Coenzyme A (CoA)IBA
01/2002
1Oxidoreductases (Dehydrogenase)IBA
01/2002

Therapy/Procedure

9Therapeutics
01/2017 - 12/2002
5Secondary Prevention
03/2012 - 05/2002
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2011 - 03/2007